Silodosin improves functional consequences of lower urinary tract obstruction secondary to benign prostate hypertrophy, a proof of concept study in the spontaneously hypertensive rat supplemented with testosterone.

Rana AssalyJulie FaugerouxMiguel LaurinSandrine CompagnieLaurent AlexandreFrançois GiulianoDelphine Behr-Roussel

Published in: BMC urology (2020)

Chronic silodosin treatment relieved storage symptoms in SHR supplemented with testosterone and decreased the frequency of non-voiding detrusor contractions during the filling phase.

Keyphrases

benign prostatic hyperplasia
urinary tract
lower urinary tract symptoms
replacement therapy
prostate cancer
blood pressure
oxidative stress
smoking cessation
combination therapy
sleep quality
depressive symptoms